These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New rulebook for gene splicers faces one more test. Wade N Science; 1978 Aug; 201(4356):600-1. PubMed ID: 353985 [No Abstract] [Full Text] [Related]
3. US extends recombinant DNA controls to private industry. Dickson D Nature; 1978 Dec 21-28; 276(5690):744. PubMed ID: 723950 [No Abstract] [Full Text] [Related]
4. US drug companies push for changes in recombinant DNA guidelines. Dickson D Nature; 1979 Mar; 278(5703):385-6. PubMed ID: 450039 [No Abstract] [Full Text] [Related]
5. US expected to exempt most recombinant DNA experiments from federal regulation. Nature; 1979 Sep; 281(5727):90. PubMed ID: 471066 [No Abstract] [Full Text] [Related]
6. US to increase public participation in regulation of DNA research. Dickson D Nature; 1978 Nov; 276(5687):430. PubMed ID: 723919 [No Abstract] [Full Text] [Related]
7. MSU faults Strobel for Dutch elm test. Roberts L Science; 1987 Sep; 237(4820):1286. PubMed ID: 3629239 [No Abstract] [Full Text] [Related]
8. Regulating human gene therapy. Areen J West VA Law Rev; 1985; 88(2):153-71. PubMed ID: 11655150 [No Abstract] [Full Text] [Related]
9. DNA: let the public choose. Wright S Nature; 1978 Oct; 275(5680):468. PubMed ID: 692727 [No Abstract] [Full Text] [Related]
10. Recombinant DNA research: the scope and limits of regulation. Krimsky S; Ozonoff D Am J Public Health; 1979 Dec; 69(12):1252-9. PubMed ID: 507257 [TBL] [Abstract][Full Text] [Related]
11. Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990. Hum Gene Ther; 1991; 2(2):131-4. PubMed ID: 1911933 [No Abstract] [Full Text] [Related]
12. In focus. The brief career of a government advisory committee: one members's perspective. The life and death of the National Human Research Protections Advisory Committee (NHRPAC). Moreno JD Am J Bioeth; 2002; 2(4):W23. PubMed ID: 12778944 [No Abstract] [Full Text] [Related]
13. DNA guidelines for further attenuation. Dickson D Nature; 1981 Mar; 290(5804):281. PubMed ID: 7207619 [No Abstract] [Full Text] [Related]
14. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of meeting, January 30, 1989. Recomb DNA Tech Bull; 1989 Jun; 12(2):69-134. PubMed ID: 2595015 [No Abstract] [Full Text] [Related]
15. NIH guidelines for research involving recombinant DNA molecules. Wilson DJ Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293 [No Abstract] [Full Text] [Related]
16. Gene splicing: 'final' federal plan. Miller JA Sci News; 1985 Sep; 128(13):198. PubMed ID: 11653694 [No Abstract] [Full Text] [Related]
17. Role of the Recombinant Advisory Committee. Johnson IS Science; 1984 Apr; 224(4646):243. PubMed ID: 6710142 [No Abstract] [Full Text] [Related]
18. NIH to review policy of DNA committee. Culliton BJ Science; 1984 Jan; 223(4631):35. PubMed ID: 6691133 [TBL] [Abstract][Full Text] [Related]
19. Recombinant DNA committee. Ahmed AK Science; 1984 Feb; 223(4635):440. PubMed ID: 6691155 [No Abstract] [Full Text] [Related]